Natera, Inc. (NTRA)

Nasdaq · Healthcare · Diagnostics & Research
$273.40-5.70%As of 2026-11-22 · USD
Last session low $271.85Last session high $288.40
52-week low $181.0052-week high $437.41
Market cap
$39.64B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)27.0In the oversold range (below 30)
MACD (12, 26, 9)-28.51Below its signal line (-21.18); histogram -7.34
Bollinger %B (20, 2)14%Inside the bands (243.20 to 451.92)
SMA 20347.56Price is 21.3% below
SMA 50375.61Price is 27.2% below
SMA 200273.08Price is 0.1% above
ATR (20)7.36% of priceAverage true range per day
52-week position36%In the middle of the 181.00 to 437.41 range

About Natera, Inc.

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Insider filings, 90 daysNo purchases and 38 sales (about $104.8M).
Latest fiscal yearEnded 2025-12-31: revenue of $2.31B and an operating margin of -13.4%.

More in Diagnostics & Research